• 1
    Bates DW, Schmitt W & Buchwald D, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med. 1993;153: 275965.
  • 2
    Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG & Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121: 9539.
  • 3
    Buchwald D, Goldenberg DL, Sullivan JL & Komaroff AL. The “chronic, active Epstein-Barr virus infection” syndrome and fibromyalgia. Arthritis Rheum. 1987;30: 11326.
  • 4
    Buchwald D & Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and chemical sensitivities. Arch Intern Med. 1994;154: 204953.
  • 5
    Wysenbeek AJ, Shapira Y & Leibovici L. Primary fibromyalgia and the chronic fatigue syndrome. Rheumatol Int. 1991;10: 2279.
  • 6
    Manu P, Matthews DA & Lane TJ. The mental health of patients with a chief complaint of chronic fatigue. Arch Intern Med. 1988;148: 22137.
  • 7
    Hudson JI, Goldenberg DL, Pope HG, Keck PE & Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992;92: 3637.
  • 8
    Komaroff AL & Buchwald D. Symptoms and signs in chronic fatigue syndrome. Rev Infect Dis. 1991;13: S8S11.
  • 9
    Goldenberg DL, Simms RW, Geiger A & Komaroff AK. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum. 1990;33: 3817.
  • 10
    Ziem G & McTamney J. Profile of patients with chemical injury and sensitivity. Environ Health Perspect. 1997;105: 41736.
  • 11
    Sivri A, Cindas A & Dincer F, et al. Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients. Clin Rheumatol. 1997;15: 2335.
  • 12
    Veale D, Kavanagh G & Fielding JF, et al. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol. 1991;30: 2202.
  • 13
    Alagiri M, Chottiner S, Ratner V, Slade D & Hanno PM. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology. 1997;49 (Suppl 5A): 527.DOI: 10.1016/s0090-4295(99)80332-x
  • 14
    Hubric Z & Robinette CD. The study of human twins in medical research. N Engl J Med. 1984;310: 43541.
  • 15
    Torgersen S. The determination of twin zygosity by means of a mailed questionnaire. Acta Genet Med Gemellol (Roma). 1979;28: 22536.
  • 16
    Eisen SA, Neuman R, Goldberg J, Rice J & True W. Determining zygosity in the Vietnam Era Twin Registry: an approach using questionnaires. Clin Genet. 1989;35: 42332.
  • 17
    Buchwald DS, Herrell R, Ashton S, Belcourt M, Schmaling K & Goldberg J. The chronic fatigue twin registry: method of construction, composition and zygosity assignment. Twin Res. 1999;2: 20311.
  • 18
    Robins LN & Helzer JE. Diagnostic Interview Schedule (DIS): Version III-A. St. Louis: Department of Psychiatry, Washington University School of Medicine; 1985.
  • 19
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
  • 20
    Wells KB, Burnan MA, Leake B & Robins LN. Agreement between face-to-face and telephone administered versions of the depression section of the NIMH Diagnostic Interview Schedule. J Psychiatr Res. 1988;22: 20720.
  • 21
    Rohde P, Lewinsohn PM & Seeley JR. Comparability of telephone and face-to-face interviews in assessing axis I and axis II disorders. Am J Psychiatry. 1997;154: 15938.
  • 22
    Breslow NE & Day NE. Statistical Methods in Cancer Research: The Analysis of Case-Control Studies. Vol. 1; New York, NY: Oxford University Press; 1980.
  • 23
    Hu FB, Goldberg J, Hedecker D & Henderson WG. Modelling ordinal responses from co-twin control studies. Stat Med. 1998;17: 95770.DOI: 10.1002/(sici)1097-0258(19980515)17:9<957::aid-sim791>;2-f
  • 24
    Gomborone JE, Gorard DA, Dewsnap PA, Libby GW & Farthing MJ. Prevalence of irritable bowel syndrome in chronic fatigue. J R Coll Physicians Lond. 1996;30: 5123.
  • 25
    Manning AP, Thompson WG, Heaton KW & Morris AF. Towards positive diagnosis of the irritable bowel. BMJ. 1978;2: 6534.
  • 26
    Aaron LA, Burke MM & Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. In press.
  • 27
    Talley NJ, Boyce PM & Jones M. Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut. 1997;41: 3948.
  • 28
    Plesh O, Wolfe F & Lane N. The relationship between fibromyalgia and temporomandibular disorders: prevalence and symptom severity. J Rheumatol. 1996;23: 194852.
  • 29
    Yunus MB. Fibromyalgia syndrome: clinical features and spectrum. J Musculoskeletal Pain. 1994;2: 519.
  • 30
    Ziem G & Donnay A. Chronic fatigue, fibromyalgia and chemical sensitivity: overlapping disorders. Arch Intern Med. 1995;155: 1913.
  • 31
    Hudson JI & Harrison Hg, Jr. Fibromyalgia and psychopathology: is fibromyalgia a form of “affective spectrum disorder?”; J Rheumatol. 1989;16 (suppl 19): 1522.
  • 32
    Watson D & Pennebaker JW. Situational, dispositional, and genetic bases of symptom reporting. In: SkeltonJA, CroyleRE, eds. Mental Representation in Health and Illness. New York: Springer Verlag; 1991: 6184.
  • 33
    Mountz JM, Bradley LA & Modell JG, et al. Fibromyalgia in women: abnormalities of regional blood flow in the thalamus and caudate nucleus are associated with low pain threshold levels. Arthritis Rheum. 1995;38: 92638.
  • 34
    Clauw DJ, Schmidt M, Radulovic D, Singer A, Katz P & Bresette J. The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res. 1997;31: 12531.DOI: 10.1016/s0022-3956(96)00051-9
  • 35
    Wolfe F, Anderson J & Harkness D, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum. 1997;40: 156070.
  • 36
    Bombardier CH & Buchwald D. Disability and health care utilization in chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Med Care. 1996;34: 92430.
  • 37
    De Leeuw JR, Ros WJ, Steenks MH, Lobbezoo-Scholte AM, Bosman F & Winnubst JA. Craniomandibular dysfunction: patient characteristics related to treatment outcome. J Oral Rehabil. 1994;21: 6778.
  • 38
    Krogstad BS, Jokstad A, Dahl BL & Vassend O. Relationships between risk factors and treatment outcome in a group of patients with temporomandibular disorders. J Orofac Pain. 1996;10: 4853.
  • 39
    Lloyd AR & Pender H. The economic impact of chronic fatigue syndrome. Med J Aust. 1992;157: 599601.